Determining the influence of the Workers Compensation Board of Manitoba's opioid policy on prescription opioid use amongst WCB recipients. Issue 3 (29th December 2020)

• Record Type: Journal Article
• Authors: Kraut, Allen; Shafer, Leigh Anne
• Is Part Of: American journal of industrial medicine. Volume 64:Issue 3(2021)
• Page Start: 170
• Page End: 177
• Publication Date: 2020-12-29
• Subjects: canada -- opioids -- workers compensation; Medicine, Industrial -- Periodicals; Médecine du travail -- Périodiques; 616.9803
• DOI: 10.1002/ajim.23216
• Languages: English
• ISSNs: 0271-3586

Abstract

Abstract: Background: Opioid medications are commonly used by Workers Compensation Board (WCB) claimants following workplace injuries. The purpose of this study is to describe the impact of an opioid management policy on opioid prescriptions amongst a WCB‐covered population compared to changes in the use of these medications in the general population of a Canadian province. Methods: We linked WCB claims data from 2006 to 2016 (13, 155 claims, 11, 905 individuals) to Manitoba provincial health records and compared opioid use amongst this group to 478, 606 individuals aged 18–65. Linear regression was performed to examine the change over time in number of individuals being prescribed opioids for various durations and dosages of 50 or more, and 120 or more morphine equivalents (ME)/day for both the WCB and Manitoba population. Results: WCB claimants totaled 2.5% of Manitoba residents aged 18–65 who were prescribed opioids for non‐cancer pain. After the introduction of the opioid use policy for the WCB population in November 2011, the number of people prescribed opioids declined 49.4% in the WCB group, while increasing 10.8% in the province as a whole. The number of individuals using 50 ME/day or more declined 43.1% in the WCB group and increased 5.8% in the province. Conclusions: Opioid management programs organized by a compensation board can lead to a substantial reduction in the prescription of opioid medications to a WCB client population, including individuals who were prescribed higher doses of these medications when compared with general trends in the community.